NCT05484947 is a clinical trial of Elisa HIV testing in Outcome, Fatal, sponsored by University of Witwatersrand, South Africa.

Who is sponsoring NCT05484947?

NCT05484947 is sponsored by University of Witwatersrand, South Africa.

What drugs are being tested in NCT05484947?

Interventions in NCT05484947: Elisa HIV testing.

What condition does NCT05484947 study?

NCT05484947 studies Outcome, Fatal.

Is NCT05484947 still recruiting?

NCT05484947 is currently completed. Last updated 2 August 2022.

Last reviewed 2022-08-02 · How we verify

NCT05484947

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The HIV Testing Trends and Outcomes at a Johannesburg Trauma ICU Unit

Completed Last updated 2 August 2022

What this trial tests

trial testing Elisa HIV testing in Outcome, Fatal in 868 participants. Completed in 18 August 2021.

Timeline

1 January 2017

Primary endpoint
31 December 2018

18 August 2021

Quick facts

Lead sponsor	University of Witwatersrand, South Africa
Status	Completed
Study type	OBSERVATIONAL
Enrollment	868
Start date	1 January 2017
Primary completion	31 December 2018
Estimated completion	18 August 2021
Sites	1 location across South Africa

Drugs / interventions tested

Elisa HIV testing

Conditions studied

Outcome, Fatal — all drugs for Outcome, Fatal →

Sponsor

University of Witwatersrand, South Africa

Who can join

18 and older, any sex, with Outcome, Fatal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A retrospective observational study on the HIV testing trend and outcomes in a trauma population admitted to a critical care unit for care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Outcome, Fatal

Currently open trials in the same condition.

NCT06146270 — Russian Registry of Surgical OutcomeS · recruiting
NCT05788861 — Invasive Group A Streptococcal Infection · recruiting

Other University of Witwatersrand, South Africa trials

Trials by the same sponsor.

NCT06821152 — Functional Performance and Acceptability Evaluation of the Miss Liberty Female Condom Compared to the FC2 Female Condom · NA · completed
NCT06955728 — A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respirato · Phase 4 · not yet recruiting
NCT06485154 — Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial · Phase 4 · active not recruiting
NCT06138600 — Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Car · Phase 3 · active not recruiting
NCT05846503 — iHEART-SA Intervention Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05484947 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Witwatersrand, South Africa
Last refreshed: 2 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05484947.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing